What You Should Know:
– Sonde Health, a Boston, MA-based health technology firm dedicated to bringing accessible well being monitoring to everybody raises $19.25 million in a Series B funding spherical led by Partners Investment, with participation from NEOM Company, KT Corporation, and current traders, together with co-founder PureTech Health and M Ventures.
– The AI vocal biomarker firm will use the funding to speed up its business progress, increase its platform into new well being circumstances, and enter new geographies.
Enterprise Vocal Biomarker Technology
Co-founded by PureTech Health, Sonde Health has the biggest and most various health-labeled voice dataset with over 1.2 million voice samples from over 85,000 topics on 4 continents. Sonde is the one vocal biomarker firm to supply AI/machine learning-based monitoring merchandise for a number of well being circumstances and to have developed the flexibility to embed its know-how into system chipsets for passive and secure well being monitoring via voice.
Today, Sonde gives its enterprise vocal biomarker know-how to corporations throughout a number of well being verticals, together with telehealth, pharmaceutical, distant affected person monitoring, and shopper/medical units. Sonde licenses its platform to clients globally in two methods:
Health Checks
Respiratory Fitness: Sonde’s platform can detect and monitor respiratory well being circumstances, like bronchial asthma, from 6 seconds of voice. Patients are participating with Sonde’s respiratory health well being checks 2+ occasions per week.
Mental Fitness: Sonde’s platform can detect and monitor proof of despair and nervousness from 30 seconds of voice. Patients are participating with Sonde’s psychological health well being checks 3+ occasions per week.
Vocal Biomarker Development
MCI, COPD, General Health: Sonde is creating novel vocal biomarkers utilizing its proprietary “research-build-validation” methodology with medical companions.
“Digital biomarkers are becoming a mainstay in healthcare. Today’s healthcare companies are realizing how vocal biomarkers can engage people earlier in their health. The data and insights found in voice can power health monitoring and patient stratification so issues can become apparent well before a costly medical event occurs,” stated David Liu, CEO of Sonde Health. “With voice and any listening device, accessible and effective health monitoring can be made available to the majority of the world.”
Discussion about this post